Young Leah C, Keuling Angela M, Lai Raymond, Nation Patrick N, Tron Victor A, Andrew Susan E
Department of Medical Genetics, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.
Carcinogenesis. 2007 Oct;28(10):2131-8. doi: 10.1093/carcin/bgm153. Epub 2007 Jul 5.
DNA mismatch repair (MMR) is a highly conserved system that repairs DNA adducts acquired during replication, as well as some forms of exogenous/endogenous DNA damage. Additionally, MMR proteins bind to DNA adducts that are not removed by MMR and influence damage-response mechanisms other than repair. Hereditary non-polyposis colorectal cancer, as well as mouse models for MMR deficiency, illustrate that MMR proteins are required for maintenance of genetic stability and tumor suppression. In both humans and mice, the phenotype associated with Msh6-associated tumorigenesis is distinct from that of Msh2. In this study, we hypothesized that Msh6-/-;p53+/- mice would display earlier tumor onset than their Msh6-/- or p53+/- counterparts, indicating that concomitant loss of these two tumor suppressors contributes to tumorigenesis via mechanisms that are only partially interrelated. We generated a Msh6-/-;p53+/- mouse model which succumbed to malignant disease at an accelerated rate and with a tumor spectrum distinct from both Msh6-/- and p53+/- models. Alteration of tumor phenotype in the Msh6-/-;p53+/- mice included a marked increase in microsatellite instability that was associated with loss of heterozygosity of the remaining p53 allele. Also, genetic instability was inversely correlated with survival. This manuscript marks the first in vivo investigation into the association between Msh6 and p53, and their combined role in the suppression of spontaneous tumorigenesis, cell survival and genomic stability. Our results support the hypothesis that p53 and Msh6 are functionally interrelated and that, with concomitant mutation, these tumor suppressors act together to accelerate tumorigenesis.
DNA错配修复(MMR)是一种高度保守的系统,可修复复制过程中获得的DNA加合物以及某些形式的外源性/内源性DNA损伤。此外,MMR蛋白会结合未被MMR去除的DNA加合物,并影响除修复之外的损伤反应机制。遗传性非息肉病性结直肠癌以及MMR缺陷的小鼠模型表明,MMR蛋白对于维持遗传稳定性和肿瘤抑制是必需的。在人类和小鼠中,与Msh6相关的肿瘤发生相关的表型与Msh2不同。在本研究中,我们假设Msh6-/-;p53+/-小鼠比其Msh6-/-或p53+/-同窝小鼠表现出更早的肿瘤发生,这表明这两种肿瘤抑制因子的同时缺失通过仅部分相关的机制促进肿瘤发生。我们构建了一个Msh6-/-;p53+/-小鼠模型,该模型以加速的速度死于恶性疾病,并且肿瘤谱与Msh6-/-和p53+/-模型均不同。Msh6-/-;p53+/-小鼠肿瘤表型的改变包括微卫星不稳定性的显著增加,这与剩余p53等位基因的杂合性丧失有关。此外,遗传不稳定性与生存率呈负相关。本论文标志着首次对Msh6和p53之间的关联及其在抑制自发肿瘤发生、细胞存活和基因组稳定性方面的联合作用进行体内研究。我们的结果支持以下假设:p53和Msh6在功能上相互关联,并且伴随突变时,这些肿瘤抑制因子共同作用以加速肿瘤发生。